文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

PVT1 通过调节 STAT1 和 CX3CL1 促进胶质母细胞瘤的增殖和巨噬细胞的免疫抑制极化。

PVT1 promotes proliferation and macrophage immunosuppressive polarization through STAT1 and CX3CL1 regulation in glioblastoma multiforme.

机构信息

Department of Pathophysiology, Beijing Neurosurgical Institute, Capital Medical University, China.

Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

出版信息

CNS Neurosci Ther. 2024 Jan;30(1):e14566. doi: 10.1111/cns.14566.


DOI:10.1111/cns.14566
PMID:38287522
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10805395/
Abstract

AIMS: This study aimed to investigate the role of plasmacytoma variant translocation 1 (PVT1), a long non-coding RNA, in glioblastoma multiforme (GBM) and its impact on the tumor microenvironment (TME). METHODS: We assessed aberrant PVT1 expression in glioma tissues and its impact on GBM cell growth in vitro and in vivo. Additionally, we investigated PVT1's role in influencing glioma-associated macrophages. To understand PVT1's role in cell growth and the immunosuppressive TME, we performed a series of comprehensive experiments. RESULTS: PVT1 was overexpressed in GBM due to copy number amplification, correlating with poor prognosis. Elevated PVT1 promoted GBM cell proliferation, while its downregulation inhibited growth in vitro and in vivo. PVT1 inhibited type I interferon-stimulated genes (ISGs), with STAT1 as the central hub. PVT1 correlated with macrophage enrichment and regulated CX3CL1 expression, promoting recruitment and M2 phenotype polarization of macrophages. PVT1 localized to the cell nucleus and bound to DHX9, enriching at the promoter regions of STAT1 and CX3CL1, modulating ISGs and CX3CL1 expression. CONCLUSION: PVT1 plays a significant role in GBM, correlating with poor prognosis, promoting cell growth, and shaping an immunosuppressive TME via STAT1 and CX3CL1 regulation. Targeting PVT1 may hold therapeutic promise for GBM patients.

摘要

目的:本研究旨在探讨浆细胞瘤变异易位 1(PVT1)作为一种长链非编码 RNA 在多形性胶质母细胞瘤(GBM)中的作用及其对肿瘤微环境(TME)的影响。

方法:我们评估了异常 PVT1 在神经胶质瘤组织中的表达及其对体外和体内 GBM 细胞生长的影响。此外,我们研究了 PVT1 影响胶质瘤相关巨噬细胞的作用。为了了解 PVT1 在细胞生长和免疫抑制性 TME 中的作用,我们进行了一系列全面的实验。

结果:由于拷贝数扩增,PVT1 在 GBM 中过度表达,与预后不良相关。升高的 PVT1 促进了 GBM 细胞的增殖,而其下调则抑制了体外和体内的生长。PVT1 抑制了 I 型干扰素刺激基因(ISGs),STAT1 是其中心枢纽。PVT1 与巨噬细胞的富集相关,并调节 CX3CL1 的表达,促进巨噬细胞的募集和 M2 表型极化。PVT1 定位于细胞核,与 DHX9 结合,在 STAT1 和 CX3CL1 的启动子区域富集,调节 ISGs 和 CX3CL1 的表达。

结论:PVT1 在 GBM 中发挥重要作用,与预后不良相关,通过调节 STAT1 和 CX3CL1 促进细胞生长并塑造免疫抑制性 TME。针对 PVT1 可能为 GBM 患者提供治疗前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0774/10805395/5d7050dd6bd1/CNS-30-e14566-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0774/10805395/38212dd441f3/CNS-30-e14566-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0774/10805395/094f3982341e/CNS-30-e14566-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0774/10805395/775ed508607a/CNS-30-e14566-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0774/10805395/fa1ec4339b5e/CNS-30-e14566-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0774/10805395/68293f993683/CNS-30-e14566-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0774/10805395/5d7050dd6bd1/CNS-30-e14566-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0774/10805395/38212dd441f3/CNS-30-e14566-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0774/10805395/094f3982341e/CNS-30-e14566-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0774/10805395/775ed508607a/CNS-30-e14566-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0774/10805395/fa1ec4339b5e/CNS-30-e14566-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0774/10805395/68293f993683/CNS-30-e14566-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0774/10805395/5d7050dd6bd1/CNS-30-e14566-g003.jpg

相似文献

[1]
PVT1 promotes proliferation and macrophage immunosuppressive polarization through STAT1 and CX3CL1 regulation in glioblastoma multiforme.

CNS Neurosci Ther. 2024-1

[2]
Long non-coding RNA plasmacytoma variant translocation 1 (PVT1) promotes glioblastoma multiforme progression via regulating miR-1301-3p/TMBIM6 axis.

Eur Rev Med Pharmacol Sci. 2020-11

[3]
RNA-binding protein DHX9 promotes glioma growth and tumor-associated macrophages infiltration via TCF12.

CNS Neurosci Ther. 2023-4

[4]
Long noncoding RNA PVT1 inhibits interferon-α mediated therapy for hepatocellular carcinoma cells by interacting with signal transducer and activator of transcription 1.

Biochem Biophys Res Commun. 2018-5-1

[5]
Long non-coding RNA PVT1 indicates a poor prognosis of glioma and promotes cell proliferation and invasion via target EZH2.

Biosci Rep. 2017-12-15

[6]
An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme.

Oncogene. 2019-8-19

[7]
Targeting long non-coding RNA PVT1/TGF-β/Smad by p53 prevents glioma progression.

Cancer Biol Ther. 2022-12-31

[8]
Modulating lncRNA SNHG15/CDK6/miR-627 circuit by palbociclib, overcomes temozolomide resistance and reduces M2-polarization of glioma associated microglia in glioblastoma multiforme.

J Exp Clin Cancer Res. 2019-8-28

[9]
PVT1 lncRNA in lung cancer: A key player in tumorigenesis and therapeutic opportunities.

Pathol Res Pract. 2024-1

[10]
Long noncoding RNA plasmacytoma variant translocation 1 is overexpressed in cutaneous squamous cell carcinoma and exon 2 is critical for its oncogenicity.

Br J Dermatol. 2024-2-16

引用本文的文献

[1]
Progenitor cells, microglia, and non-coding RNAs: Orchestrators of glioblastoma pathogenesis and therapeutic resistance.

Noncoding RNA Res. 2025-8-5

[2]
Anoikis resistance in gastric cancer: a comprehensive review.

Cell Death Dis. 2025-7-15

[3]
Combined anti-PD-L1 and anti-VEGFR2 therapy promotes the antitumor immune response in GBM by reprogramming tumor microenvironment.

Cell Death Discov. 2025-4-3

[4]
Upregulation of the interferon-inducible antiviral gene RSAD2 in neuroendocrine prostate cancer via PVT1 exon 9 dependent and independent pathways.

J Biol Chem. 2025-4

[5]
Long Non-Coding RNAs in Malignant Human Brain Tumors: Driving Forces Behind Progression and Therapy.

Int J Mol Sci. 2025-1-15

[6]
Anoikis-Related Long Non-Coding RNA Signatures to Predict Prognosis and Immune Infiltration of Gastric Cancer.

Bioengineering (Basel). 2024-9-5

[7]
Interplay between JAK/STAT pathway and non-coding RNAs in different cancers.

Noncoding RNA Res. 2024-4-7

[8]
Glioblastoma stem cell long non-coding RNAs: therapeutic perspectives and opportunities.

Front Genet. 2024-7-2

[9]
Alterations in CX3CL1 Levels and Its Role in Viral Pathogenesis.

Int J Mol Sci. 2024-4-18

本文引用的文献

[1]
lncRNA XLOC013218 promotes cell proliferation and TMZ resistance by targeting the PIK3R2-mediated PI3K/AKT pathway in glioma.

Cancer Sci. 2022-8

[2]
The IRENA lncRNA converts chemotherapy-polarized tumor-suppressing macrophages to tumor-promoting phenotypes in breast cancer.

Nat Cancer. 2021-4

[3]
clusterProfiler 4.0: A universal enrichment tool for interpreting omics data.

Innovation (Camb). 2021-7-1

[4]
Long non-coding RNA SMASR inhibits the EMT by negatively regulating TGF-β/Smad signaling pathway in lung cancer.

Oncogene. 2021-5

[5]
Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients.

Genomics Proteomics Bioinformatics. 2021-2

[6]
PVT1 Knockdown Inhibits Autophagy and Improves Gemcitabine Sensitivity by Regulating the MiR-143/HIF-1α/VMP1 Axis in Pancreatic Cancer.

Pancreas. 2021-2-1

[7]
Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways.

Front Immunol. 2020-11-23

[8]
LncRNA ANCR promotes glioma cells invasion, migration, proliferation and inhibits apoptosis via interacting with EZH2 and repressing PTEN expression.

Cancer Gene Ther. 2021-9

[9]
Long noncoding RNA plasmacytoma variant translocation gene 1 promotes epithelial-mesenchymal transition in osteosarcoma.

J Clin Lab Anal. 2021-1

[10]
Visualizing and interpreting cancer genomics data via the Xena platform.

Nat Biotechnol. 2020-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索